Skip to main content
. 2020 Apr 8;19(10):1200–1221. doi: 10.1080/15384101.2020.1749467

Table 2.

The correlation between miR-106a and Smad7 expression levels and the clinic pathological features of gastric cancer.

    miR-106a
  Smad7
 
Characteristics Number Fold change ± SD P-value Fold change ± SD P-value
Sex          
 Male 22 2.5118 ± 1.27580 0.135 0.7862 ± 1.02471 0.255
 Female 18 1.9917 ± 0.74372   0.4909 ± 0.38040  
Age (years)          
 ≥60 23 2.4683 ± 1.08208 0.202 0.6995 ± 0.98368 0.680
 <60 17 2.0200 ± 1.07642   0.5910 ± 0.49821  
Tumor site          
 Cardia 7 2.4686 ± 1.20333 0.599 0.6204 ± 0.35941 0.971
 Body 5 2.6400 ± 1.00055   0.7324 ± 0.80316  
 Autumn 28 2.1654 ± 1.09385   0.6474 ± 0.90220  
Size (cm)          
 >5 9 3.3433 ± 1.05711 0.001# 0.3257 ± 0.17514 0.014*
 3-5 26 2.0335 ± 0.94325   0.5908 ± 0.48357  
 ≤3 5 1.6300 ± 0.55032   1.5693 ± 1.87072  
Histology grade          
 Well 5 1.1440 ± 0.33366 0.011* 0.3842 ± 0.13025 0.432
 Moderate + poor 35 2.4397 ± 1.06374   0.6918 ± 0.85567  
Lymph node          
 Yes 24 2.6200 ± 1.20633 0.013* 0.7118 ± 0.98777 0.580
 No 16 1.7644 ± 0.61991   0.5653 ± 0.42512  
Serosal invasion          
 Yes 27 2.5885 ± 1.13914 0.008# 0.6977 ± 0.93522 0.621
 No 13 1.6323 ± 0.61242   0.5608 ± 0.45211  
TNM stage          
 Ⅰ + Ⅱ 9 1.5900 ± 1.00169 0.029* 1.2937 ± 1.50424 0.005#
 Ⅲ + Ⅳ 31 2.4774 ± 1.04471   0.4675 ± 0.28795  

*P < 0.05, #P < 0.01.